Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 71-80 of 93 for cerebrovascular

Edit search filters
  1. Cognitive Advancement and Recovery in VNS-Rehabilitation (CARE)

    Rochester, MN

  2. A Study to Assess Symptoms in Working Age Stroke Survivors

    Rochester, MN

  3. A Study of the Clinical Presentation and Natural History of Vertebrobasilar Non-Saccular and Dolichoectatic (Types of Symptom and Brain Location) Aneurysms

    Rochester, MN

  4. Identification of risk factors and risk markers in Patients with Cavernous Malformations

    Rochester, MN

  5. A Study of the Effects of Cytochrome P450 Enzyme on the Metabolism of Nimodipine after Aneurysm

    Jacksonville, FL

  6. A Study to Identify Late-Occurring Complications in Childhood Cancer Survivors

    Rochester, MN

  7. Cavernous Malformation Prospective Registry

    Rochester, MN

  8. Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on Recovery (DISCOVERY)

    Rochester, MN

  9. Clinical Outcomes Following Shunting for Idiopathic Normal Pressure Hydrocephalus (iNPH)

    Rochester, MN

  10. Parkinson's Disease iPS Cell Line Research Consortium

    Scottsdale/Phoenix, AZ, Jacksonville, FL

.

Mayo Clinic Footer